Common Contracts

SETTLEMENT AGREEMENT

Settlement Agreement • April 22nd, 2022 • Massachusetts

• Contract Type
  Settlement Agreement
• Filed
  April 22nd, 2022
• Jurisdiction
  Massachusetts

This Settlement Agreement is made and entered into on April 8, 2022 by and between plaintiffs United Food and Commercial Workers Health and Welfare Fund of Northeastern Pennsylvania, Louisiana Health Service & Indemnity Company d/b/a Blue Cross and Blue Shield of Louisiana, and HMO Louisiana., Inc. (“Plaintiffs”), individually and on behalf of the End Payor Classes (defined below) (who, together with Plaintiffs are referred to collectively as the “End-Payor Classes”), by and through Lowey Dannenberg, P.C. attorneys Gerald Lawrence and Renee Nolan, and The Dugan Law Firm APLC attorneys James Dugan, David Scalia, and TerriAnne Benedetto, in their capacity as attorneys and lead class counsel (“Lead Class Counsel”) for the End Payor Classes in In re: Ranbaxy Generic Drug Application Antitrust Litigation, Master File No. 19-md-02878-NMG (D. Mass.) (the “Action”), and defendants, Sun Pharmaceutical Industries Ltd. and Ranbaxy, Inc. (“Ranbaxy”)1, by and through Kirkland & Ellis LLP attorneys